Tower Research Capital (TRC)’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,181
| Closed | -$3K | – | 6967 |
|
|
2022
Q2 | $3K | Sell |
2,181
-9,051
| -81% | -$9.46K | ﹤0.01% | 5495 |
|
|
2022
Q1 | $12K | Sell |
11,232
-2,582
| -19% | -$1.95K | ﹤0.01% | 4132 |
|
|
2021
Q4 | $10K | Buy |
13,814
+4,766
| +53% | +$3.85K | ﹤0.01% | 4657 |
|
|
2021
Q3 | $8K | Sell |
9,048
-10,468
| -54% | -$12.6K | ﹤0.01% | 4608 |
|
|
2021
Q2 | $32K | Buy |
19,516
+4,904
| +34% | +$8.2K | ﹤0.01% | 3438 |
|
|
2021
Q1 | $31K | Sell |
14,612
-12,914
| -47% | -$26.8K | ﹤0.01% | 3553 |
|
|
2020
Q4 | $34K | Sell |
27,526
-46,371
| -63% | -$55.3K | ﹤0.01% | 3482 |
|
|
2020
Q3 | $90K | Buy |
73,897
+46,576
| +170% | +$56.6K | ﹤0.01% | 3229 |
|
|
2020
Q2 | $32K | Buy |
+27,321
| New | +$25.3K | ﹤0.01% | 3408 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | – | – | 4246 |
|
|
2019
Q4 | $0 | Sell |
100
-2,253
| -96% | -$2.73K | ﹤0.01% | 4679 |
|
|
2019
Q3 | $3K | Buy |
+2,353
| New | +$3.32K | ﹤0.01% | 3619 |
|
|
2019
Q2 | – | Sell |
-8,247
| Closed | -$12K | – | 4544 |
|
|
2019
Q1 | $12K | Sell |
8,247
-4,099
| -33% | -$6.25K | ﹤0.01% | 2606 |
|
|
2018
Q4 | $18K | Sell |
12,346
-10,382
| -46% | -$15.9K | ﹤0.01% | 2042 |
|
|
2018
Q3 | $42K | Buy |
+22,728
| New | +$44.1K | ﹤0.01% | 1878 |
|
|
2016
Q4 | – | Sell |
-35
| Closed | – | – | 4588 |
|
|
2016
Q3 | $0 | Buy |
+35
| New | +$43 | ﹤0.01% | 4737 |
|
|
2016
Q2 | – | Sell |
-187
| Closed | – | – | 5187 |
|
|
2016
Q1 | $0 | Buy |
+187
| New | +$188 | ﹤0.01% | 5202 |
|
|
2015
Q4 | – | Sell |
-5,608
| Closed | -$12K | – | 5250 |
|
|
2015
Q3 | $12K | Sell |
5,608
-539
| -9% | -$1.05K | ﹤0.01% | 2185 |
|
|
2015
Q2 | $12K | Buy |
+6,147
| New | +$17.4K | ﹤0.01% | 2560 |
|
|
2014
Q4 | – | Sell |
-2,140
| Closed | -$5K | – | 4912 |
|
|
2014
Q3 | $5K | Sell |
2,140
-1,614
| -43% | -$10.8K | ﹤0.01% | 3333 |
|
|
2014
Q2 | $44K | Buy |
+3,754
| New | +$42.5K | 0.01% | 1369 |
|
|
2014
Q1 | – | Sell |
-432
| Closed | -$8K | – | 5107 |
|
|
2013
Q4 | $8K | Sell |
432
-186
| -30% | -$3.02K | ﹤0.01% | 3218 |
|
|
2013
Q3 | $10K | Buy |
+618
| New | +$8.68K | ﹤0.01% | 3223 |
|
Tower Research Capital (TRC)'s MBII Position: Q3 2022 in Review
Tower Research Capital (TRC) sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 2,181 shares — an estimated $3K sold.
Tower Research Capital (TRC) first reported a position in MBII in Q3 2013 and held it in 22 quarters. The position peaked at $90K in Q3 2020. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Tower Research Capital (TRC) reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,181 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $3K.
- Tower Research Capital (TRC) first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 22 quarters.
- Tower Research Capital (TRC)'s Marrone Bio Innovations, Inc. position peaked at $90K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.